Ticker Details
OPKO Health, Inc. OPKO Health Inc is a diversified healthcare company. Its business includes diagnostics and provision of pharmaceutical products.
IPO Date:	November 2, 1995
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$888.11M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.11 | 2.71%
Avg Daily Range (30 D):	$0.03 | 2.18%
Avg Daily Range (90 D):	$0.02 | 1.73%

Institutional Daily Volume
Avg Daily Volume:	3.26M
Avg Daily Volume (30 D):	2.2M
Avg Daily Volume (90 D):	2.57M

Trade Size
Avg Trade Size (Sh.):	295
Avg Trade Size (Sh.) (30 D):	285
Avg Trade Size (Sh.) (90 D):	352

Institutional Trades
Total Institutional Trades:	4,507
Avg Institutional Trade:	$1.81M
Avg Institutional Trade (30 D):	$1.2M
Avg Institutional Trade (90 D):	$1.31M
Avg Institutional Trade Volume:	.39M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2M
Avg Closing Trade (30 D):	$1.2M
Avg Closing Trade (90 D):	$1.32M
Avg Closing Volume:	452.62K

News

Feb 12, 2026 @ 1:00 PM OPKO Health to Report Fourth Quarter 2025 Financia... Source: Na

Feb 4, 2026 @ 1:00 PM OPKO Health and Entera Bio Expand Partnership to A... Source: Opko Health, Inc. And Entera Bio Ltd.

Nov 18, 2025 @ 1:00 PM Entera Bio to Participate in the 8th Annual Everco... Source: Miranda Toledano

Oct 8, 2025 @ 12:02 PM NextPlat Issues CEO Shareholder Update Letter Source: David Phipps

Aug 8, 2025 @ 9:17 PM Entera Bio Beats Q2 EPS Estimates Source: Jesterai

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-.3	$-.04	$-.3
Diluted EPS	$-.3	$-.04	$-.3
Revenue	$606.88M	$148.45M	$606.88M
Gross Profit	$205.94M	$64.03M	$205.94M
Net Income / Loss	$-225.68M	$-31.26M	$-225.68M
Operating Income / Loss	$-117.41M	$-38.32M	$-117.41M
Cost of Revenue	$400.94M	$84.43M	$400.94M
Net Cash Flow	$-66.3M	$-46.31M	$-66.3M
PE Ratio